comprehensive ophthalmic solutions

Explore Eversight’s latest offerings to enhance corneal surgery and support advanced eye disease treatment

Your single source for ophthalmic tissues: New offerings from Eversight

By Caithlin Lopes, Senior Director, Business Development

As a trusted partner for ophthalmologists and corneal surgeons, Eversight has long been committed to providing high-quality, expertly prepared donor corneal tissue. This year, we have expanded our offerings with three groundbreaking solutions: amniotic membrane, BrightMEM™, and KeraNatural®. These additions complement our suite of comprehensive ophthalmic solutions, such as halo® and Vital Tears™, solidifying Eversight as a single source for all your surgical tissue needs. 

View all offerings
Whether you're treating complex ocular diseases, advanced keratoconus or looking for solutions to accelerate corneal healing, our latest offerings provide cutting-edge options to improve patient outcomes. 

Amniotic membrane: Promoting ocular healing

Image
Eversight’s amniotic membrane offering leverages the natural anti-inflammatory and anti-scarring properties of human placenta tissue, procured after cesarean birth. This versatile allograft from Corza Medical is sterilized and preserved for ophthalmic use, offering a highly effective treatment for non-healing chronic wounds and other ocular surface conditions. 
Amniotic membrane is indicated for treating conditions such as pterygium, corneal ulcers, limbal stem cell deficiency and ocular surface burns. Eversight offers Ambio2®, Ambio5®, and AmbioDisk®—all designed to promote epithelial healing and protect the ocular surface, with shelf lives of up to five years. Whether you need surgical or clinic-ready solutions, Eversight has you covered. 
Learn more
On-demand training

BrightMEM™: Enhancing corneal regeneration

BrightMEM™
For surgeons tackling severe corneal disorders, BrightMEM™ by Brightstar Therapeutics presents a novel approach to tissue regeneration. This innovative corneal allograft is derived from Descemet's membrane, serving as a protective barrier while promoting the regeneration of the corneal epithelium. 
Clinical results in 2024 have shown no instances where the corneal epithelium failed to regenerate when treated with BrightMEM. Its ability to resist degradation and stimulate limbal stem cell growth makes it an exceptional choice for ocular surface reconstruction. As with all Eversight solutions, BrightMEM is supported by extensive training and educational resources through Eversight Academy. 
Learn more
On-demand training

KeraNatural®: A revolution in corneal contouring

KeraNatural®
The treatment of advanced keratoconus often requires precision, and KeraNatural® provides an exciting new option for reshaping the cornea with minimal invasion. Unlike a full-thickness corneal transplant, KeraNatural employs sterile allograft rings and arcs to help reshape the cornea’s curvature, improving visual acuity with less risk. 
KeraNatural is highly biocompatible, with minimal risk of extrusion, and offers the flexibility of reversibility or adjustment as needed. Available in multiple thicknesses and diameters, KeraNatural provides a versatile solution that can be tailored to each patient’s unique needs. 
Learn more
On-demand training

Why Eversight for comprehensive ophthalmic solutions?

At Eversight, we believe that offering innovative tissue solutions is a critical part of our mission to restore sight and prevent blindness. We are dedicated to providing unmatched customer service and personalized support for ophthalmic surgeons worldwide. Whether you’re working on a routine corneal transplant or tackling more complex cases, Eversight is your trusted partner in delivering the best possible outcomes for your patients. 

Our latest offerings—amniotic membrane, BrightMEM™ and KeraNatural®—further enhance our suite of comprehensive ophthalmic solutions. Contact us today to learn how these solutions can be integrated into your practice. 

Previous Getting the gift to surgeons & patients
All News
Next Eversight advances global DMEK training at 2024 World Ophthalmology Congress
In this season of gratitude, Eversight has launched a matching

#GivingTuesday

campaign to impact even more lives. Please consider supporting Eversight and help us earn a generous $4,000 match from our Board of Directors.
GIVE TODAY
close-link

Stay in touch

Help us tailor your Eversight experience by subscribing to information that is meaningful to you.
Subscribe now
close-link
Search